Abstract
The emergence of pathogenic viruses is a worldwide frequent cause of diseases and, therefore, the design of treatments for viral infections stands as a significant research topic. Despite many efforts, the production of vaccines is faced with many obstacles and the high rate of viral resistance caused a severe reduction in the efficacy of antiviral drugs. However, the attempt of developing novel natural drugs, as well as the exertion of medicinal plants, may be an applicable solution for the treatment of viral diseases. Boswellia species exhibited a wide range of pharmacological activities in various conditions such as bronchial asthma, rheumatism, and Crohn’s illness. Additionally, pharmacological studies reported the observance of practical antiviral activities from different parts of this substance, especially the oleo-gum-resin. Therefore, this work provided an overview on the antiviral properties of Boswellia species and their potential therapeutic effects in the field of COVID-19 pandemic.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Viral diseases are one of the most common worldwide health obstacles (Meganck and Baric 2021). Viruses are classified into two species including DNA virus and RNA virus, which are generally consisted of double-strand or single-strand. Single-stranded RNA viruses contain positive-sense-single-stranded RNA or negative-sense-single-stranded RNA (Durmuş and Ülgen 2017; Hughes and Hughes 2007). Accordingly, human diseases caused by RNA viruses involve SARS, common cold, influenza, and hepatitis C or E, as well as Coronavirus disease (COVID-19) that is induced by the SARS-CoV-2 virus. The treatment of viral infections are typically a difficult challenge mainly due to the virus mutations, drug resistance, side effects, and high cost of antiviral medicines (Cosar et al. 2021; Caligiuri et al. 2016; Behravan et al. 2011). The attention of many scientists was focused on bioactive compounds, secondary metabolites, and the phytochemicals of medicinal plants for the design and development of legal drugs against viral diseases, which would lack or at least contain the most negligible rate of side effects (Jansi et al. 2021; Jassim and Naji 2003). As a genus of the Burseraceae family, Boswellia species were traditionally exerted for the treatment of numerous diseases such as chronic inflammatory illnesses, arthritis, blood disorders, cardiovascular diseases, diarrhea, ringworm, vaginal discharges, jaundice, fevers, mouth sores, dire throat, bronchitis, asthma, coughing, hair loss, hemorrhoids, syphilitic diseases, diaphoretic, astringent, and diuretic (Rashan et al. 2019; Upaganlawar and Ghule 2009). Different parts of Boswellia species such as roots, barks, leaves and oleo-gum-resin, can be used as safe therapeutic agents with potent antioxidant, antimicrobial, anti-inflammatory, anticancer, anticoagulant, antidepression, and antifungal activities (Prakash et al. 2014; Marefati et al. 2022; Bhushan et al. 2013; Pan et al. 2015; Adake et al. 2013).
Nowadays, a wide range of brand formulations composed of Boswellia species, including 5-Loxin®, Aflapin®, and Sallaki®, are exerted for different purposes such as hepatoprotective, antiarthritic, antihyperlipidemic, antiinflammatory, antiatherosclerotic, and analgesic activities (Sengupta et al. 2010; Knaus and Wagner 1996; Sharma et al. 2016). This review presented a summary on the antiviral effects of Boswellia species with a focus on its potent beneficial abilities against COVID-19 for the development of an alternative therapy in near future.
Search strategy
The relevant articles were retrieved through the application of scientific databases such as “Google Scholar,” “Scopus,” “PubMed,” “Science Direct,” and “Wiley Online Library” using the keywords “Boswellia” or “frankincense” and “virus” or “viral.” We also gathered information from related local and foreign books.
Botany and phytochemistry
Bursereae, Canarieae, and Protieae are the three subtribes of Burseraceae family, which include 19 genera, as well as approximately 700 species that are all shrubby and small to medium trees (2–8 m in height). Next to the exfoliated outer bark, the smaller leaves are glabrous with 7–9 tiny toothy leaflets. The flowers are composed of five lobes with disk-shaped internal stamens. The genus Boswellia is approximately consisted of 21 species that are native to Africa, southern Arabia, and India (Fig. 1(. Boswellia species is bisexual with self-pollinate properties and grows in regions with hot and dry climate (Siddiqui 2011; Sultana et al. 2106). The diversity of various active phytocompounds that exist in this genus are caused by variable weather and climate (Rashan et al. 2019; Kadam et al. 2021; Pilkhwal and Dhaneshwar 2019). Oleo-gum-resin is exuded from scratching the surface of Boswellia tree, which is an aromatic resin with a clear, sweet-smelling, and golden yellow appearance. The prominent producers of Oleo-gum-resin are comprised of four species including B. carteri, B. frereana, B. sacra, and B. serrata (Greve et al. 2017; DeCarlo et al. 2018; Johnson et al. 2021). This material is consisted of essential oil, gum, and resin. The essential oil of Boswellia species contains various components such as monoterpene, diterpene, sesquiterpene, ether derivatives of alcohol, and ester derivatives that are capable of displaying different activities including antioxidant, acetyl-cholinesterase-inhibition, antimicrobial, anticancer, and antibiofilm effects (Satpathy 2020; Sharma et al. 2007; Gupta et al. 2011; Aldahlawi et al. 2020). Moreover, the gum is composed of different sugars including arabinose, xylose, and galactose (Sharma et al. 2007).
In addition to oleo-gum-resin, the other parts of this plant such as the leaves, roots, and bark can be exerted for the treatment of various diseases and disorders. A study reported the achievement of varying chemical compositions from different extracts of B. dalzielii leaves, which included phenolics, flavonoids, tannins, anthocyanins, and sugar. The highest and lowest yields were recorded in the cases of methanol (16.08%) and ethyl acetate (0.03%) extracts, respectively, while the product was 1.12% of the mass of dry leaves in the case of essential oil. Apparently, dissimilar pharmacological impacts were observed from different types of extracts. For instance, the inhibition percentage of cyclohexane extract in IGROV-1 cell lines was 92.60%, whereas the dichloromethane extract caused 65.10% of inhibition in OVCAR-3 cell lines. However, there were no signs of any toxic effects from methanolic extract (Kohoude et al. 2017). Boswellia resin is a mixture of more than 200 diverse ingredients such as b-boswellic acid, acetyl-b-boswellic acid, 11-keto-b-boswellic acid, acetyl-ll-keto-b-boswellic acid, 3a-hydroxy-urs-9, 12-diene-24-oic acid, 3a-Hydroxy-lup-20(29)-en-24-oic acid, 3 hydroxyl urs-9, and 11-keto-α-boswellic acid. In addition, this resin is capable of displaying different activities similar to antiinflammatory, antiarthritic, antiulcer, and analgesic effects.
Safety and toxicity of Boswellia species
Certain investigations were performed on the Safety and toxic properties of Boswellia species in different animal models. Singh et al. reported the oral administration of B. serrata in rat models for 90 days at three different doses, i.e. 100, 500, and 1000 mg/kg body weight (B. wt.) /day. Their results confirmed the safety of B. serrata in dosages up to 500 mg/kg B.wt. without the inducement of any side effects (Singh et al. 2012). According to recent studies, different cytogenetic test results approved the ability of boswellic acids in facilitating a high rate of safety in Wistar rats, while lacking any signs of toxicity up to 1000 mg/kg when compared to positive controls (Sharma et al. 2009).
Antiviral activities
Next to being exerted for vaccine formulations, Boswellia species can produce a variety of bioactive constituents with the potential of inhibiting different types of DNA or RNA viruses similar to Influenza, Hepatitis C, Chikungunya, Vesicular stomatitis, Epstein–Barr, Herpes Simplex, Newcastle disease, and Avian Infectious bronchitis viruses (Fig. 2(.
Hepatitis C virus (HCV)
Hepatitis C virus (HCV) is a universal health concern due to standing as the main cause of liver inflammation and injury. The envelopment of this virus implicates positive polarity and single-stranded RNA virus that belongs to the Flaviviridae family (Vega and Barbancho 2020). There are currently no competent vaccines or efficient antiviral medicines available against hepatitis C. However, the exerted combination therapies include pegylated interferon alpha (PegIFN-α) injections and antiviral nucleoside analogue ribavirin (RBV) that cause many side effects such as hyperglycemia, pancreatitis, hypertension, and peptic ulcer, as well as fever, flu, anemia, and depression (Schaefer et al. 2007). Hussein et al. performed an assessment on the inhibitory impacts of 76 plants, which are commonly used in Sudanese for the treatment of hepatitis C virus (HCV) protease (PR). Apparently, eight samples displayed notable antiviral inhibitory activity including Acacia nilotica, Piper cubeba, Embelia schimperi, Quercus infectoria, Trachyspermum ammi, Q. infectoria, Syzygium aromaticum, and B. carteri. It is stated that the root of B. carteri, which was extracted by Methanol and H2O, exhibited great inhibitory properties against HCV (≥ 90% inhibition at 100 µg/mL) (Table 1) (Hussein et al. 2000).
Chikungunya virus (CHIKV)
Being the alphavirus of Togaviridae family, Chikungunya virus (CHIKV) is a single-stranded RNA virus with positive polarity that is transferred to humans through mosquito bites (Caglioti et al. 2013). The common symptoms of this infection include headache, fever, rash, joint swelling, muscle pain, fatigue, and nausea. Currently, there are no vaccines or special antiviral drugs available for CHIKV infection, while experts have been trying different approaches to reduce the symptoms (Simon et al. 2011). Von Rhein et al. investigated the antiviral effects of acetyl-11-keto-β-boswellic acid or curcumin against CHIKV, which is one of the most important bioactive compounds of B. serrata gum resin. Their results confirmed the ability of acetyl-11-keto-β-boswellic acid and curcumin in inhibiting the viral infection and proved their efficient blockage against the gene transfer of CHIKV Env or VSV-G-pseudotyped lentiviral vectors into HEK 293T cells (Table 1) (Rhein et al. 2016).
Herpes simplex virus (HSV)
Herpes simplex virus (HSV) is a member of herpesviridae family that is enveloped with double-stranded DNA and cause infections and diseases in animals and humans (Corey and Spear 1986). Herpes simplex virus (HSV) types 1 and 2 (HSV-1 and HSV-2, respectively) are the two serotypes of Herpesviridae family. The infection of HSV-1 is mainly oral and involves the lips, gums, or throat. It mostly infects the genital mucosa and stands as a risk factor for sexually transmitted diseases such as HIV infection (Buxbaum et al. 2003). There are some antiviral medicines available for the treatment of HSV infection including acyclovir, famciclovir, penciclovir, and valacyclovir, however, the clinical process is often disturbed by drug resistance (Pasternak and Hviid 2010). The work of Goswami et al. indicated the ability of B. serrata oleo-gum-resin, as well as one of its major constituent known as β-boswellic acid, to effectively inhibit Herpes Simplex virus 1(HSV) infection (effective concentration (EC50): 5.2–6.2 and 12.1–14.63 μg/ml, respectively) through the modulation of NF-κB that is essential for virus replication and p38MAPK pathway. In addition, their observations mentioned the considerable down-regulation of NF-κB, and p38 MAP-kinase activation along with the reduced expression of tumor necrosis factor α (TNF-α), Interleukin 1β (IL-1β), and interleukin-6)IL-6(that are involved in the scheming process of NF-κB signaling (Goswami et al. 2018). In another study, Mothana et al. evaluated the antiviral activity of 25 different plant species extracts, used in traditional Yemeni medicine, against influenza virus type A and herpes simplex virus type 1. Among their samples, the methanol extract of B. elongata was one of the most effective drugs against herpes simplex. In addition, they proved the strong anti-bacterial effects of aqueous and methanol extracts of B. elongata as well (Mothana et al. 2006). In another work, Badria et al. investigated the anti-herpes activity of oleo-gum-resin of frankincense (B. carteri Bird wood). In comparison to the nine isolated compounds from oleo-gum-resin, their results confirmed the inducement of strongest impact by the total extract against the herpes simplex type I virus (Table 1) (Badria et al. 2016).
Epstein–Barr virus (EBV)
Epstein–Barr virus (EBV) is an enveloped virus that contains a DNA core with a 184-kbp long member of herpes virus family. This infection frequently occurs in adolescents with the symptoms of inflamed throat, sore throat, enlarged spleen, swollen liver, fatigue, fever, and rash. Generally, EBV spreads through body fluids, blood transfusion, and sexual intercourse. There are no vaccines or any specific treatments available for the treatment of infection (Dunmire et al. 2018; Feng et al. 2004). Akihisa et al. extracted different compounds from the resin of B. carteri to study their antiviral activity against Epstein–Barr virus. Some of these compounds caused strong cytotoxic effects with the IC50 value of 4.1–82.4 µM against human neuroblastoma cells and displayed potent inhibitory impacts on EBV-EA induction. Their work proposed the potential benefits of using the triterpene acid ingredients of methanolic extract of B. carteri resin for preventing the inducement of chemical carcinogenesis (Table 1) (Akihisa et al. 2006).
Influenza virus
Influenza virus belongs to the Orthomyxoviridae family and contains single-stranded and negative-sense RNA. Since ACE2 functions as a receptor for cellular entry in this virus, it seems that its inhibition may be effective in blocking its entrance (Cottey et al. 2001; Chang et al. 2021). In conformity to previous reports, Mothana et al., studied the antiviral effects of different plant extracts used in traditional Yemeni medicine. Their outcomes indicated that the aqueous extracts of B. ameero, and B. elongate and methanol extract of B. elongate caused the strongest impacts against influenza virus A. In addition, they observed a decrease in the nucleic acid synthesis of influenza virus upon their exposure to the extracts of B. ameero (Table 1) (Mothana et al. 2006). Another study assessed the outcomes of diet therapy for inhibiting viral infections through the oral and inhalation usage of essential oils, Saccharomyces cerevisiae, B. Carteri, and Zinc. This treatment was able to prevent influenza infection and increase the number of leukocytes in the blood samples of animals through an appropriate diet. B. Carteri is capable of effectively strengthening the immune system, producing the alkaline pH of blood, and preventing viral infections (Table 1) (Ali and Hashim 2020).
Vesicular stomatitis virus (VSV)
As a member of Rhabdoviridae family, Vesicular stomatitis virus (VSV) is a negative-strand RNA virus that causes infections in humans and animals. Human infections are commonly associated with exposure to infected animals. Insect bites commonly induce VSV infection in animals such as cattle, swine, and horses, which can be diagnosed by the symptoms of foot and mouth disorders (Garbutt et al. 2004; Brown 1987). According to the study of von Rhein et al., VSV vector particles and the viral infections of 293T cells were considerably inhibited by the exertion of B. serrata gum-resin extract and curcumin. According to related experiments, the main mechanism of viral inhibition by Acetyl-11-keto-b-boswellic acid implicates the blockage of virus entry into the target cells (Table 1) (Rhein et al. 2016).
Newcastle disease virus (NDV)
Newcastle disease virus (NDV) belongs to the Paramyxoviridae family that has proved its importance in poultry industry by causing infections in domestic poultry. NDV is a single strand of negative-sense RNA virus that is extremely transmissible and has remained as the main poultry disease (Ganar et al. 2014; Munir et al. 2012). In the work of Ohemu et al., the stem bark of B. dalzielii and Enantia chlorantha methanol extracts were used to study their impact on the virus of Newcastle disease (ND) through an in ovo assay on embryonated eggs. Preliminary phytochemical screening recorded the presence of carbohydrates, steroids, triterpenes, cardiac glycosides, tannins, and flavonoids in the stem bark extract of B. dalzielii. Interestingly, this product exhibited remarkable antiviral effects against NDV while the embryos were observed to survive throughout every studied concentration (Ohemu et al. 2018). In another report, Ohemu et al. investigated the impact of using fractions and extracts of B. dalzielii on NDV through the application of chicken embryonated eggs. The performance of solvent–solvent fractionation for the methanol extract of B. dalzielii required the application of solvents with various polarity, while four fractions were generated that included hexane, ethyl acetate, n-butanol, and aqueous. Tannins, flavonoids, saponin, terpenoids, and steroids were detected in the extract of stem bark and fractions of B. dalzielii. In comparison to the results of other fractions, the methanol stem bark extract of B. dalzielii displayed a considerably stronger anti-NDV activity (Ohemu et al. 2020).
Avian infectious bronchitis virus (AIBV)
As a member of Coronaviridae family, Avian infectious bronchitis virus (AIBV) was observed to cause diseases only in chickens, while containing many antigenic types that differ in various regions. As a positive-sense single-stranded RNA virus, AIBV implicates the inducement of nephropathogenic infection and respiratory disorders. In addition, depression, ruffled feathers, wet droppings, greater water intake, and death are included among the other reported symptoms. Although wide vaccination was attempted as a solution to control the prevalence of AIBV, however, this procedure was faced with the challenging obstacle of resistance. So far, science has been incapable of developing any effective drugs or vaccines against this virus due to its highly mutable nature (Ignjatović and Sapats 2000; Bande et al. 2015). Lestari et al. exerted an allantoic fluid medium to investigate the effects of natural oil blend of B. serrata, Gardenia jasminoides, Commiphora myrrha, Daucus carota, and Foeniculum vulgare on Avian Infectious Bronchitis Virus H120 strain (AIBV H120). To counteract the lethal dosage of virus, various concentrations of natural oil blend (NOB) were inoculated into the allantoic fluid. Although the embryos of positive control group were annihilated, yet they reported the survival of treated samples with natural oil blend and revealed the capability of essential oil Blend in performing the in vitro inhibition of AIBV H120 (Table 1) (Keri Lestari et al. 2021).
Use Boswellia species in vaccine formulations
Natural gums and mucilage can be used in the designs of nasal drug or vaccine delivery due to their mucoadhesive properties. Next to the ability of mucosa in covering the nasal cavity, the applied drug/vaccine can be directly transferred to the systemic blood circulation without facing the hepatic first pass effect and intestinal metabolism. However, oral vaccines can provide certain advantages such as simple usage, low cost, and mucosal immune responses (Smart et al. 1984; Peppas and Sahlin 1996; Emikpe et al. 2016; Yonesi and Kamrani 2019). In addition, natural gums proved to be an appropriate choice for delaying the drug release, which has led to the growing interest in the application of these polymers in sustained drug and vaccine delivery (Bhosale et al. 2014; Manjula et al. 2014; Cox et al. 1999). In this section, a discussion is presented on the role of Boswellia gum in the preparation and formulation of various antiviral vaccines.
Vaccine against Newcastle disease virus (NDV)
As described in Section 5.7., NDV is a significant avian virus with the ability to cause fatal infection in many species of birds. However, the applications of NDV vaccines were effective in reducing the cases of this disease (Sinkovics and Horvath 2000). Ola et al. reported an evaluation on the role of microbeads throughout the vaccine delivery of Newcastle Disease (ND) in chickens. Vaccine-containing beads were produced by the ionotropic-gelation technique that implicates the application of aluminum sulfate, sodium alginate, and B. carteri gum. This study involved 60 local birds of 8-weeks-old, which were divided into four groups (15 birds per group). The vaccination was orally administered into the samples as they reached 65 days old. Accordingly, group A was treated with vaccine-loaded bead (VLB), group B received the treatment of vaccine alone (VA), group C was treated with unloaded bead (UB), and group D did not receive any beads or vaccines (NBNV/negative control). The application of microbeaded-vaccine (group A) resulted in increasing the time of vaccine release and prolonged the systemic immune responses of birds (Table 1) (Ola et al. 2021).
Vaccine against Peste des petits ruminants virus (PPRV)
Peste des petits ruminants virus (PPRV) is a fatal viral disease of domestic and wild small ruminants that can be diagnosed by the common symptoms of fever, pneumonia, cough, diarrhea, respiratory inflammation, ocular discharges, oral necrosis, and digestive tracts (Kumar et al. 2014; Kwiatek et al. 2007). Mumin et al. reported the preparation of gums from B. frereana, B. carteri, and Commiphora myrrha, as well as their investigation results on their mucoadhesive feature and immunomodulatory effects on intranasal vaccination against PPR. This study involved the participation of forty-eight animal samples (24 goats and 24 sheep) that were divided into eight groups (3 goats and 3 sheep in each group). Then, they prepared two ratios (1:1, 1:2) of gum-vaccine combinations and performed nasal vaccination. On the days 14, 28, 42, and 56 post vaccination, the existing antibody against PPRV was measured by the utilization of H-based PPR bELISA. The best inhibition was observed from the case of B. carteri-vaccine combination group at a ratio of 1:1, which displayed a similar antibody titer to that of a subcutaneous route. Therefore, this method can be suggested as a safe and noninvasive alternative for PPR vaccination (Table 1) (Mumin et al. 2020).
SARS-CoV-2
Overview of SARS-CoV-2
Coronavirus disease (COVID-19) is a novel viral illness generated from the SARS-CoV-2 virus and has caused the death of millions of people worldwide since the start of its pandemic that was around two years ago. Despite the presence of available antiviral drugs, there is a continuous worldwide effort to control and limit this disease (Organization 2020; Rothan and Byrareddy 2020). The major transmission routes of COVID-19 include the composed droplets and aerosol particles upon coughing and speaking, as well as making direct contact with an infected patient. Dry cough, loss of taste or smell, running nose, tiredness, high fever, and body ache are the common symptoms of this illness (Pullen et al. 2020). Coronaviruses (CoVs) are a very diverse family of enveloped positive-sense single-stranded RNA viruses. Alpha-coronavirus, Beta-coronavirus, Gamma-coronavirus, and Delta-coronavirus are the subfamilies of Orthocoronavirinae (Pal et al. 2020). The cytokine storm process of COVID-19 is a crucial factor that begins with the cellular entry of SARS-CoV-2 by cellular ACE2 receptor and proceeds with the provoking of immune response through the production of interferon (IFN), granulocyte–macrophage colony-stimulating factor (GM-CSF) and TNF-α, and interleukin-6 (IL-6), as well as the infiltration of macrophages and neutrophils into the lung tissue (Zhou et al. 2020). Other studies reported the observance of a larger amount of IL-2, IL-6, IL-7, IL-10, IP-10, MCP-1, TNF-α in patients with severe COVID-19 infection, while facing the exceeding counts of neutrophil, which is in contrast to that of the mild patients (Hu et al. 2021).
Evaluating the efficiency of Boswellia species against SARS-CoV-2 by molecular docking
Computational methods were broadly exerted for discovering novel drugs throughout the last decade. During the course of SARS-CoV-2 infection, in silico analysis and molecular docking studies were immensely contributed to the topics of drug evolution action and potential inhibitors against this illness. Virtual screening were developed for the wide database of active compounds or known drugs through the performance of docking procedures against SARS-CoV-2. The candidate drugs were able to cause a great inhibitory effect on SARS-CoV-2 and also reduce the burden of in vitro and clinical experiments (Heiat et al. 2021). The in silico study of Kadhim et al. involved an evaluation on the inhibitory effects of boswellic acid and beta-boswellic acid against SARS-CoV-2 virus (Kadhim et al. 2021; Caliebe et al. 2021). Considering how the reproduction of this virus depends on the binding of its spikes to the cell receptors, the docking studies of this survey were conducted using Molecular Graphic Laboratory (MGL) tools and AutoDock Vina application to gather data on the interaction of virus spikes and alpha-Boswellic acid or beta-Boswellic acid, which resulted in indicating the existing of a high affinity among them and also confirmed the safety of using large doses of these compounds in humans due to their LC50 values (Kadhim et al. 2021). In another study, molecular docking and molecular dynamics simulations were used to screen a medicinal plant library for detecting potential compounds against COVID-19. As a result, Qamar et al., introduced nine phytochemical ingredients with potential inhibitory effects on COVID-19 (ul Qamar MT et al. 2020). Furthermore, Heiat et al. reviewed the available articles on various aspects of COVID-19, including the prevention, diagnosis, and treatment areas, while mentioning the studies that used computational methods and computer modeling approaches such as molecular dynamics (MD) simulation technique. Their conclusion emphasized the necessity of applying both traditional and modern sciences for designing combating approaches towards COVID-19 (Heiat et al. 2021). In another study, Roy et al. also evaluated the potential of existing bioactive compounds in B. serrata against the Mpro enzyme of SARS-CoV-2 through the application of computational techniques. Five compounds, including Euphane, Ursane, α-Amyrin, Phytosterol, and 2,3-Dihydroxyurs-12-en-28-oic, exhibited maximum binding affinities with the binding energies of − 10.47 kcal/mol, − 10.41 kcal/mol, − 9.99 kcal/mol, − 9.94 kcal/mol, and − 9.72 kcal/mol, respectively (Roy and Menon 2021).
Anti-inflammatory and anti-bacterial effects of Boswellia species
The anti-inflammatory and anti-bacterial properties of Boswellia species could be considered as a treatment capacity against the symptoms of SARS-CoV-2. Chib et al. evaluated the anti-inflammatory potential of isolated compounds from B. ovalifoliolata. Two compounds (3a-hydroxy-tirucall-8,24-dien-21-oic acid and one type of triterpenoid) were taken from the ethanolic extract of oleo-gum-resin of B. ovalifoliolata, which were able to remarkably prevent the TNF-α expression in murine neutrophils and cause a decrease in the production of interleukin IL-6, IL-8, and nitric oxide. Furthermore, there are reports on the inhibition of 5-lipoxygenase enzyme and leukotriene by acetyl-11-keto-β-boswellic acid that is a pentacyclic triterpene in the Gum resin extracts of B. serrata (Chib et al. 2014). According to other studies, B. serrata can enhance the clinical results of ischaemic stroke and conventional therapies due to the anti-inflammatory effect of Boswellic acids. This substance can inhibit certain pro-inflammatory cytokines such as TNF-α, interleukin-1β (IL-1β), interferon-gamma (IFN-γ), and 5-lipoxygenase (5-LOX), which would lead to the blockage of inflammatory mediators such as leukotrienes. Another study displayed the superior enrichment of Aflapin® by the acetyl-11-keto-β-boswellic acid extract of B. serrata when compared to that of 5-Loxin®, which is capable of providing a better protection from the induced proteolytic degradation by inflammatory and facilitating the recovery of articular cartilage damage (Sengupta et al. 2010). The antimicrobial activity of resin B. serrata was evaluated and compared with Ciprofloxacin in the concentrations of 25, 50, 75, and 100 mg/ml against eight Gram positive and negative bacteria (Ismail et al. 2014).
Clinical trials of Boswellia species
A lot of clinical trials have been performed on Boswellia species (Kimmatkar et al. 2003). Boswellia extracts displayed some promise for the treatment of rheumatoid arthritis, asthma, knee osteoarthritis, collagenous colitis, and Crohn’s disease (Karimifar et al. 2017). Kulkarni et al. presented a report on the clinical trials of herbomineral formulation for rheumatoid arthritis treatment, which included rhizomes of Curcuma longa, roots of Withania somnifera, the stem of B. serrata, and a zinc complex (Kulkarni et al. 1991). Another study showed that oral supplementation of B. serrata extract containing 3‐acetyl‐11‐keto‐β‐boswellic acid and β‐boswellic acid remarkably raised physical function by decreasing pain and stiffness compared with placebo. Additionally, radiographic assessment displayed that B. serrata extract remarkably increased between the knee joints and decreased osteophytes formation compared with the placebo. More importantly, B. serrata extract treatment comprising 30% 3‐acetyl‐11‐keto‐β‐boswellic acid and β‐boswellic acid significantly decreased high‐sensitive C‐reactive protein values compared with the placebo group (Majeed et al. 2019). Barzin Tond et al. examined the effects of Infawell® syrup, a Boswellia extract formulation enriched for boswellic acids, (10 ml of Infawell® syrup thrice daily (30 ml/day for 14 days) in patients with moderate COVID-19. Their outcomes indicated the inducement of a reduction in the percentage of neutrophils, neutrophil-to-lymphocyte ratio levels, CRP, LDH, IL–6, and TNF–α levels, while heightening the percentage of lymphocytes and improving the clinical symptoms such as dyspnea, cough, myalgia, headache, and gustatory dysfunction and olfactory (Barzin Tond et al. 2022). In another study, forty female survivors of COVID-19, who were experiencing low energy levels after recovery, were treated by aromatherapy with Longevity™ (twice daily for 14 days) essential oils that were extracted from Thymus vulgaris, Citrus sinensis, Eugenia caryophyllus, and B. carteri. In conformity to the results, aromatherapy blend can notably enhance the energy levels of women who were experiencing fatigue after recovering from COVID-19 (Hawkins et al. 2022).
Conclusion
In this review, we discussed the antiviral actions of Boswellia species that may be capable of displaying potential therapeutic activity against COVID-19, considering how different parts of this plant, especially oleo-gum-resin, is exerted in the treatment of several viral diseases. Besides, next to being implicated in the intranasal vaccine of animal viral diseases, gum-resin can increase the time of release. According to common knowledge, Boswellia species can display anti-inflammatory, antimicrobial, anti-asthmatic, antioxidant, antifibrotic, and anti-platelet activities, which consequently confirms its stance as a potential candidate for the treatment of COVID-19 symptoms. However, a vast range of clinical studies is required to estimate the accurate potential of antiviral Boswellia species to act as a leading approach towards the discovery and design of appropriate drugs.
Data availability
Enquiries about data availability should be directed to the authors.
References
Adake P, Chandrashekar R, Rao S (2013) Potentiating antidepressant action of Boswellia serrata in acute models of depression: a preclinical study. Indo Am J Pharm Res 3:4407–4412
Akihisa T, Tabata K, Banno N, Tokuda H, Nishihara R, Nakamura Y et al (2006) Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri. Biol Pharm Bull 29(9):1976–1979
Aldahlawi AM, Alzahrani AT, Elshal MF (2020) Evaluation of immunomodulatory effects of Boswellia sacra essential oil on T-cells and dendritic cells. BMC Complementary Med Ther 20(1):1–14
Ali WA, Hashim HR (2020) Inhibit of the virus infections by using aromatic oils, saccharomyces cerevisiae, Boswellia carterii and zinc. Syst Rev Pharm 11(4):561–569
Badria FA, Abu-Karam M, Mikhaeil BR, Maatooq GT, Amer M (2016) Anti-herpes activity of isolated compounds from frankincense. Biosci Biotechnol Res Asia 1(1):1–10
Bande F, Arshad SS, Hair Bejo M, Moeini H, Omar AR (2015) Progress and challenges toward the development of vaccines against avian infectious bronchitis. J Immunol Res 2015:424860–424872
Barzin Tond S, Balenci L, Khajavirad N, Salehi M, Tafakhori A, Shahmohammadi MR et al (2022) Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial. Inflammopharmacology 30(2):465–475
Behravan J, Salmasi Z, Ramezani M, Sabeti NZ (2011) Euphorbia microsciadia percolation and Soxhlet extracts exhibit antiviral activity. Clin Biochem 13(44):S325
Bhosale RR, Osmani RAM, Moin A (2014) Natural gums and mucilages: a review on multifaceted excipients in pharmaceutical science and research. Int J Pharmacogn Phytochem Res 15(4):901–912
Bhushan S, Kakkar V, Pal HC, Guru SK, Kumar A, Mondhe D et al (2013) Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata. Mol Pharm 10(1):225–235
Brown F (1987) The family Rhabdoviridae. The rhabdoviruses. Springer, Boston, pp 1–8
Buxbaum S, Geers M, Gross G, Schöfer H, Rabenau H, Doerr H (2003) Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? Med Microbiol Immunol 192(3):177–181
Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L (2013) Chikungunya virus infection: an overview. New Microbiol 36(3):211–227
Caliebe RH, Scior T, Ammon HP (2021) Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: bioinformatic studies. Arch Pharm 354(11):2100160
Caligiuri P, Cerruti R, Icardi G, Bruzzone B (2016) Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 22(1):145
Chang S-Y, Huang K-Y, Chao T-L, Kao H-C, Pang Y-H, Lu L et al (2021) Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses. Sci Rep 11(1):1–13
Chib R, Kumar M, Rizvi M, Sharma S, Pandey A, Bani S et al (2014) Anti-inflammatory terpenoids from Boswellia ovalifoliolata. RSC Adv 4(17):8632–8637
Corey L, Spear PG (1986) Infections with herpes simplex viruses. N Engl J Med 314(11):686–691
Cosar B, Karagulleoglu ZY, Unal S, Ince AT, Uncuoglu DB, Tuncer G et al (2021) SARS-CoV-2 mutations and their viral variants. Cytokine Growth Factor Rev 63:10–22
Cottey R, Rowe C, Bender B (2001) Influenza virus current protocols in immunology. John Wiley & Sons, Inc, Maryland
Cox PJ, Khan KA, Munday DL, Sujja-Areevath J (1999) Development and evaluation of a multiple-unit oral sustained release dosage form for S (+)-ibuprofen: preparation and release kinetics. Int J Pharm 193(1):73–84
de la Vega BA, Barbancho ML (2020) Hepatitis víricas. Pediatríaintegral 7:15
DeCarlo A, Johnson S, Poudel A, Satyal P, Bangerter L, Setzer WN (2018) Chemical variation in essential oils from the oleo-gum resin of Boswellia carteri: a Preliminary investigation. Chem Biodivers 15(6):e1800047
Dunmire SK, Verghese PS, Balfour HH Jr (2018) Primary epstein-barr virus infection. J Clin Virol 102:84–92
Durmuş S, Ülgen KÖ (2017) Comparative interactomics for virus–human protein–protein interactions: DNA viruses versus RNA viruses. FEBS Open Bio 7(1):96–107
Emikpe BO, Oyebanji VO, Odeniyi MA, Salaam AM, Oladele OA, Jarikre TA et al (2016) Ex-vivo evaluation of the mucoadhesive properties of Cedrela odorata and Khaya senegalensis gums with possible applications for veterinary vaccine delivery. Springerplus 5(1):1–8
Feng W-h, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R et al (2004) Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96(22):1691–1702
Ganar K, Das M, Sinha S, Kumar S (2014) Newcastle disease virus: current status and our understanding. Virus Res 184:71–81
Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Möller P, Wagner R et al (2004) Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 78(10):5458–5465
Goswami D, Mahapatra AD, Banerjee S, Kar A, Ojha D, Mukherjee PK et al (2018) Boswellia serrata oleo-gum-resin and β-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-кB and p38 MAP kinase signaling. Phytomedicine 51:94–103
Greve HL, Kaiser M, Brun R, Schmidt TJ (2017) Terpenoids from the oleo-gum-resin of Boswellia serrata and their antiplasmodial effects in vitro. Planta Med 83(14/15):1214–1226
Gupta A, Khajuria A, Singh J, Singh S, Suri K, Qazi G (2011) Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice. Int Immunopharmacol 11(8):968–975
Hawkins J, Hires C, Keenan L, Dunne E (2022) Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial. Complement Ther Med 67:102823
Heiat M, Hashemi-Aghdam M-R, Heiat F, Rastegar Shariat Panahi M, Aghamollaei H, Moosazadeh Moghaddam M et al (2021) Integrative role of traditional and modern technologies to combat COVID-19. Expert Rev Anti Infect Ther 19(1):23–33
Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250–256
Hughes AL, Hughes MAK (2007) More effective purifying selection on RNA viruses than in DNA viruses. Gene 404(1–2):117–125
Hussein G, Miyashiro H, Nakamura N, Hattori M, Kakiuchi N, Shimotohno K (2000) Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv 14(7):510–516
Ignjatović J, Sapats S (2000) Avian infectious bronchitis virus. Revue scientifique et technique (International Office of Epizootics) 19(2):493–508
Ismail SM, Aluru S, Sambasivarao K, Matcha B (2014) Antimicrobial activity of frankincense of Boswellia serrata. Int J Curr Microbiol App Sci 3(10):1095–1101
Jansi RS, Khusro A, Agastian P, Alfarhan A, Al-Dhabi NA, Arasu MV et al (2021) Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents. Sci Total Environ 759:143539
Jassim SA, Naji MA (2003) Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 95(3):412–427
Johnson S, DeCarlo A, Satyal P, Dosoky NS, Sorensen A, Setzer WN (2021) The chemical composition of single-tree Boswellia frereana resin samples. Nat Prod Commun 16(9):1934578X211043727
Kadam U, Khalkar K, Kadam V (2021) Biochemical profile of Boswellia serrata and Rhus mysorensis. J Drug Deliv Ther 11(4–S):131–133
Kadhim MM, Salman AW, Zarzoor AM, Kadhum WR (2021) Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: a theoretical study. J Mol Liq 337:116440
Karimifar M, Soltani R, Hajhashemi V, Sarrafchi S (2017) Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trial. Clin Rheumatol 36(8):1849–1853
Keri Lestari HB, Babikyan Y, Megantara I, Jha RK, Kusuma ASW, Novantiana MP, Sudirman FX (2021) Deactivation of Avian infectious bronchitis virus H120 using natural oil blend on in vitro medium. Asian J Poult Sci 15:24–30
Kimmatkar N, Thawani V, Hingorani L, Khiyani R (2003) Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine 10(1):3–7
Knaus U, Wagner H (1996) Effects of boswellic acid of Boswellia serrata and other triterpenic acids on the complement system. Phytomedicine 3(1):77–80
Kohoude MJ, Gbaguidi F, Agbani P, Ayedoun M-A, Cazaux S, Bouajila J (2017) Chemical composition and biological activities of extracts and essential oil of Boswellia dalzielii leaves. Pharm Biol 55(1):33–42
Kulkarni R, Patki P, Jog V, Gandage S, Patwardhan B (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33(1–2):91–95
Kumar N, Maherchandani S, Kashyap SK, Singh SV, Sharma S, Chaubey KK et al (2014) Peste des petits ruminants virus infection of small ruminants: a comprehensive review. Viruses 6(6):2287–2327
Kwiatek O, Minet C, Grillet C, Hurard C, Carlsson E, Karimov B et al (2007) Peste des petits ruminants (PPR) outbreak in Tajikistan. J Comp Pathol 136(2–3):111–119
Majeed M, Majeed S, Narayanan NK, Nagabhushanam K (2019) A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res 33(5):1457–1468
Manjula B, Srinatha A, Sridhar B (2014) Evaluation of hydrophilic polymers and their combinations in formulation of sustained-release matrix tablets of water-soluble drug. Ind J Pharmaceut Educ Res 48:48–59
Marefati N, Beheshti F, Etemadizadeh P, Hosseini M, Anaeigoudari A (2022) Gum resin extract of Boswellia serrata attenuates lipopolysaccharide-induced inflammation and oxidative damage in hepatic and renal tissues of rats. Asian Pac J Trop Biomed 12(1):20–25
Meganck RM, Baric RS (2021) Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat Med 27(3):401–410
Mothana RA, Mentel R, Reiss C, Lindequist U (2006) Phytochemical screening and antiviral activity of some medicinal plants from the island Soqotra. Phytother Res an Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv 20(4):298–302
Mumin FI, Emikpe BO, Odeniyi MA (2020) Evaluation of mucoadhesive property and the effect of Boswellia carteri gum on intranasal vaccination against small ruminant morbillivirus infection (PPR). J Immunoassay Immunochem 41(3):311–321
Munir M, Zohari S, Abbas M, Berg M (2012) Sequencing and analysis of the complete genome of Newcastle disease virus isolated from a commercial poultry farm in 2010. Adv Virol 157(4):765–768
Ohemu T, Agunu A, Chollom S, Okwori V, Dalen D, Olotu P (2018) Preliminary phytochemical screening and antiviral potential of methanol stem bark extract of Enantia chlorantha Oliver (Annonaceae) and Boswellia dalzielii Hutch (Burseraceae) against Newcastle disease in Ovo. EJMP 25:1–8
Ohemu TL, Ahmed A, Alemika TE, Chollom SC, Yakubu TP, Dafam DG et al (2020) In-ovo biological activity of Boswellia dalzielii stem bark extract and fractions against Newcastle disease virus. J Pharmacogn Phytother 12(3):62–70
Ola O, Jarikre TA, Adeniran G, Odeniyi M, Emikpe B (2021) Evaluation of oral phytogenic microbeaded Newcastle disease vaccine delivery in indigenous chicken. J Immunoassay Immunochem 42:1–11
Organization WH (2020) Coronavirus disease (COVID-19): situation report. 171
Pal M, Berhanu G, Desalegn C, Kandi V (2020) Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. https://doi.org/10.7759/cureus.7423
Pan Y-N, Liang X-X, Niu L-Y, Wang Y-N, Tong X, Hua H-M et al (2015) Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products. J Ethnopharmacol 172:118–123
Pasternak B, Hviid A (2010) Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304(8):859–866
Peppas NA, Sahlin JJ (1996) Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 17(16):1553–1561
Pilkhwal N, Dhaneshwar S (2019) An update on pharmacological profile of Boswellia serrata. Asian J Pharm Clin Res 12(5):49–56
Prakash B, Mishra PK, Kedia A, Dubey N (2014) Antifungal, antiaflatoxin and antioxidant potential of chemically characterized Boswellia carterii Birdw essential oil and its in vivo practical applicability in preservation of Piper nigrum L. fruits. LWT Food Sci Technol 56(2):240–247
Pullen MF, Skipper CP, Hullsiek KH, Bangdiwala AS, Pastick KA, Okafor EC et al (eds) (2020) Symptoms of COVID-19 outpatients in the United States. Open forum infectious diseases. Oxford University Press, US
Rashan L, Hakkim FL, Idrees M, Essa MM, Velusamy T, Al-Baloshi M et al (2019) Boswellia gum resin and essential oils: potential health benefits−an evidence based review. Int J Nutr Pharmacol Neurol Dis 9(2):53
Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433
Roy A, Menon T (2021) Evaluation of bioactive compounds from Boswellia serrata against SARS-CoV-2. Vegetos 35:1–11
Satpathy R (2020) Therapeutic importance and application of boswellic acid from the plant Boswellia serrate. Advanced pharmacological uses of medicinal plants and natural products. IGI Global, Pennsylvania, pp 302–315
Schaefer M, Hinzpeter A, Mohmand A, Janssen G, Pich M, Schwaiger M et al (2007) Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology 46(4):991–998
Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV et al (2010) Comparative efficacy and tolerability of 5-Loxin® and Aflapin® against osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci 7(6):366
Sharma A, Mann A, Gajbhiye V, Kharya M (2007) PHCOG REV.: plant review phytochemical profile of Boswellia serrata: an overview. Pharmacogn Rev 1(1):131–142
Sharma R, Singh S, Singh G, Khajuria A, Sidiq T, Singh S et al (2009) In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodents. Phytomedicine 16(12):1112–1118
Sharma A, Shalini T, Sriranjini S, Venkatesh B (2016) Management strategies for Janu Sandhigata Vata vis-a-vis osteoartheritis of knee: a narrative review. Ayu 37(1):11–17
Siddiqui M (2011) Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci 73(3):255
Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C (2011) Chikungunya virus infection. Curr Infect Dis Rep 13(3):218–228
Singh P, Chacko KM, Aggarwal M, Bhat B, Khandal R, Sultana S et al (2012) A-90 day gavage safety assessment of Boswellia serrata in rats. Toxicol Int 19(3):273
Sinkovics JG, Horvath JC (2000) Newcastle disease virus (NDV): brief history of its oncolytic strains. J Clin Virol 16(1):1–15
Smart J, Kellaway I, Worthington H (1984) An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 36(5):295–299
Sultana A, Rahman KU, Padmaja A, Rahman SU (2013) Boswellia serrata Roxb. a traditional herb with versatile pharmacological activity: a review. Int J Pharm Sci Res 4(6):2106
Ul Qamar MT, Alqahtani SM, Alamri MA, Chen L-L (2020) Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 10(4):313–319
Upaganlawar A, Ghule B (2009) Pharmacological activities of Boswellia serrata Roxb.-mini review. Ethnobot Leafl 2009(6):10
von Rhein C, Weidner T, Henß L, Martin J, Weber C, Sliva K et al (2016) Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. Antiviral Res 125:51–57
Yonesi M, Kamrani A (2019) An efficient isolation plan for extraction of the mucilage collected from the seeds within the lallemantia for pharmaceutical purpose. Plant Cell Biotechnol Mol Biol 20(7–8):294–304
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273
Acknowledgements
The authors are thankful to Mashhad University of Medical Sciences (Mashhad, Iran).
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jamshidi, Z., Hashemi, M., Yazdian-Robati, R. et al. Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2. Inflammopharmacol 30, 1541–1553 (2022). https://doi.org/10.1007/s10787-022-01037-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-022-01037-4